Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$6.24
0.5910.44%
At close: Aug 17, 5:00 PM EST
$6.23
-0.01-0.16%
After Hours: 5:19 PM EST
ARS Pharmaceuticals Inc
SPRYNASDAQ
Earnings: Q2 2026 Earnings were released on Thu Aug 13th, after the market close
Conference Call: The most recent conference call started at 4:30 PM, 4 days agoClick to view the webcast
ARS Pharmaceuticals Market Sentiment
Market sentiment signals for ARS Pharmaceuticals (SPRY): analyst consensus, short interest, options flow and insider activity.
Key Signals
Analyst Consensus— Outperform
Short Interest▲ 31.2% short float
Options Flow▼ 2.48 P/C ratio
Insider Activity— N/A
Analyst Consensus
Outperform
7 analysts
Options Flow (P/C)
2.48
More puts — Bearish
252 calls · 625 puts
Avg Consensus PT
$29
+357.5%
Highest Price Target
$40
+542.1%
Roth Capital
Lowest Price Target
$19
+205.0%
Wedbush
Short Interest
31.2%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
Recent Analyst Actions
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Jun 25, 2026 | Leerink Partners | Roanna Ruiz— | +285.2% | $25 → $24 | Maintained | Outperform |
| May 28, 2026 | Cantor Fitzgerald | Josh Schimmer— | +381.5% | $12 → $30 | Maintained | Overweight |
